1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. India Emerging Infectious Disease Diagnostics Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising prevalence of infectious diseases
3.2.1.2. Growing private healthcare sector
3.2.1.3. Rapid advancements in diagnostic technologies
3.2.1.4. Rising awareness about early diagnosis
3.2.2. Restraints
3.2.2.1. Limited healthcare infrastructure
3.2.2.2. Low healthcare expenditure
3.2.2.3. Lack of skilled personnel
3.2.3. Opportunities
3.2.3.1. Increasing emphasis on preventive healthcare
3.2.3.2. Growth of telemedicine
3.2.3.3. Creasing government initiatives
3.2.4. Challenges
3.2.4.1. Presence of counterfeit and substandard diagnostic products
3.2.4.2. Data Privacy and Security
3.2.4.3. Price Sensitivity among significant portion of the Indian population
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. India Emerging Infectious Disease Diagnostics Market: Pricing Analysis
5. India Emerging Infectious Disease Diagnostics Market: Marketing Strategies
6. India Emerging Infectious Disease Diagnostics Market Overview
6.1. Market Size & Forecast, 2019-2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.1.1. Polymerase Chain Reaction (PCR)
6.2.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.1.3. Next-Generation Sequencing (NGS)
6.2.1.4. Immunodiagnostics
6.2.1.5. Other Technologies
6.2.2. By Type of Infections
6.2.2.1. Bacterial
6.2.2.2. Viral
6.2.2.3. Fungal
6.2.2.4. Others
6.2.3. By Disease Type
6.2.3.1. Respiratory Infections
6.2.3.2. Sexually Transmitted Infections (STIs)
6.2.3.3. Gastrointestinal Infections
6.2.3.4. Others
6.2.4. By Application
6.2.4.1. Laboratory Testing
6.2.4.2. Point-of-Care Testing
6.2.5. By End User
6.2.5.1. Hospitals and Clinics
6.2.5.2. Diagnostic Laboratories
6.2.5.3. Others
6.2.6. By Region
6.2.6.1. North India
6.2.6.2. South India
6.2.6.3. East India
6.2.6.4. West India
7. North India Emerging Infectious Disease Diagnostics Market Overview
7.1. Market Size & Forecast, 2019-2030
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Type of Infections
7.2.3. By Disease Type
7.2.4. By Application
7.2.5. By End User
8. South India Emerging Infectious Disease Diagnostics Market Overview
8.1. Market Size & Forecast, 2019-2030
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Type of Infections
8.2.3. By Disease Type
8.2.4. By Application
8.2.5. By End User
9. East India Emerging Infectious Disease Diagnostics Market Overview
9.1. Market Size & Forecast, 2019-2030
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Type of Infections
9.2.3. By Disease Type
9.2.4. By Application
9.2.5. By End User
10. West India Emerging Infectious Disease Diagnostics Market Overview
10.1. Market Size & Forecast, 2019-2030
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Type of Infections
10.2.3. By Disease Type
10.2.4. By Application
10.2.5. By End User
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. India Emerging Infectious Disease Diagnostics Company Market Share Analysis, 2023
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
12. Impact of Escalating Geopolitical Tensions in India Emerging Infectious Disease Diagnostics Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
13.1. Abbott Laboratories
13.2. Becton, Dickinson and Company
13.3. bioMerieux S.A.
13.4. Bio-Rad Laboratories, Inc.
13.5. DANAHER CORPORATION
13.6. DiaSorin S.p.A.
13.7. Hoffmann-La Roche Ltd
13.8. QIAGEN N.V.
13.9. Thermo Fisher Scientific Inc.
13.10. Siemens Healthineers AG
13.11. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
15.1. Qualitative Research
15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
15.3.1. Secondary Research
15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumption & Limitation
* Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable